Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.